ABCC5 p.Gly1249Ala

[switch to full view]
Comments [show]
Publications
PMID: 16393888 [PubMed] Zhang J et al: "Metabolism and transport of oxazaphosphorines and the clinical implications."
No. Sentence Comment
637 These mainly included C-24T (promoter), G1249A (exon 10), G2026C (exon 16), T2125C (exon 17), C2302T (exon 18), C2366 (exon 18), A3517T (exon 25), G3449 (exon 25), C3972T (exon 28), and G4348A (exon 31).
X
ABCC5 p.Gly1249Ala 16393888:637:40
status: NEW
Login to comment

PMID: 18220559 [PubMed] Yu XQ et al: "Multidrug resistance associated proteins as determining factors of pharmacokinetics and pharmacodynamics of drugs."
No. Sentence Comment
405 Important Single Nucleotide Polymorphisms (SNPs) of MRP Genes MRP Chromosomal location Amino acid variation Nucleotide variation Location References Cys43Ser Thr73Ile G128C C218T Exon2 Exon2 [239] Arg433Ser G1299T Exon10 [258] Gly671Val G2012T Exon16 [259] Arg723Gln G2168A Exon17 [239] MRP1 16p13.11-p13.12 Arg1058Gln G3173A Exon23 [239] C-24T Promoter [100, 239] Val417Ile G1249A Exon10 [100, 238, 239] Gly676Arg G2026C Exon16 [237] Try709Arg T2125C Exon17 [236] Arg768Trp Ser789Phe C2302T C2366T Exon18 Exon18 [100, 238, 239] I1173F R1150H A3517T G3449A Exon25 Exon25 [240] Ile1324Ile C3972T Exon28 [100, 239] MRP2 10q23-24 Ala1450Thr G4348A Exon31 [100, 238, 239] (Table 2) contd….
X
ABCC5 p.Gly1249Ala 18220559:405:375
status: NEW
Login to comment

355 These include C-24T (promoter), G1249A (exon 10), G2026C (exon 16), T2125C (exon 17), C2302T (exon 18), C2366 (exon 18), A3517T (exon 25), G3449 (exon 25), C3972T (exon 28) and G4348A (Exon 31).
X
ABCC5 p.Gly1249Ala 18220559:355:32
status: NEW
Login to comment

PMID: 12769780 [PubMed] Toffoli G et al: "Pharmacogenetics of irinotecan."
No. Sentence Comment
244 Two of them, one (C24T) located in the promoter of the gene, and one (G1249A) on exon 10, showed a considerable allelic frequency (12.326.1%, and 18.3-31.2%, respectively depending on the Jewish ethnic group) [9] but their effect on MRP2 activity is still unknown.
X
ABCC5 p.Gly1249Ala 12769780:244:70
status: NEW
Login to comment

PMID: 17001288 [PubMed] Owen A et al: "Pharmacogenetics of HIV therapy."
No. Sentence Comment
106 Recently, the pharmacogenetics of ABCC2 (C - 24T and G1249A), ABCC4 (C1612T, A3463G, G3724A and T4131G) ABCG2 (G34A and C421A) and CYP3A5 were assessed in the context of zidovudine and lamivudine triphosphate concentrations [44].
X
ABCC5 p.Gly1249Ala 17001288:106:53
status: NEW
Login to comment

PMID: 20103563 [PubMed] Klaassen CD et al: "Xenobiotic, bile acid, and cholesterol transporters: function and regulation."
No. Sentence Comment
7118 Nucleotide Change Amino Acid Change In Vitro Function Protein Expression/Localization ABCC1 MRP1 G128C C43S 1↔ Intracellular C218T T73I 1↔ Normal C257T S92F 2↔ Normal C350T T117M 2↔ Normal G689A R230Q ↔ Normal G1057A V353M N.D. N.D. G1299T R433S 2↔ Normal G1898A R633Q 2↔ Normal G2012T G671V ↔ Normal G2168A R723Q 2 Normal G2965A A989T 2↔ Normal G3140C C1047S 1↔ Normal G3173A R1058Q ↔ Normal C4535T S1512L ↔ Normal ABCC2 MRP2 C-24T N.D. N.D. G1058A R353H N.D. N.D. G1249A V417I ↔ Normal C2366T S789F 12 Intracellular T2780G L927R N.D. N.D. C3298T R1100C N.D. N.D. G3299A R1100H N.D. N.D. T3563A V1188E N.D. N.D. G4348A A1450T ↔ Normal/Intracellular G4544A C1515Y N.D. N.D. ABCC3 MRP3 G32A G11D ↔ Normal C202T H68Y N.D. N.D. G296A R99Q N.D. Normal C1037T S346F 2 Normal C1537A Q513K N.D. N.D. T1643A L548Q N.D. N.D. G1820A S607N 2 Normal C2221T Gln741STOP N.D. N.D. G2293C V765L ↔ Normal G2395A V799M N.D. N.D. C2758T P920S 1 Normal G2768A R923Q 1 Normal C3657A S1219R N.D. N.D. C3856G R1286G ↔ Normal G3890A R1297H N.D. N.D. C4042T R1348C 1 Normal A4094G Q1365R ↔ Normal C4141A R1381S ↔ Intracellular C4217T T1406M N.D. N.D. G4267A G1423R N.D. N.D. ABCC4 MRP4 C52A L18I N.D. N.D. C232G P78A 2↔ Normal T551C M184T N.D. N.D. G559T G187W 2 Reduced A877G K293E ↔ Normal G912T K304N ↔ Normal C1067T T356M N.D. N.D. C1208T P403L 2↔ Normal G1460A G487E 2 Normal A1492G K498E ↔ Normal A1875G I625M N.D. N.D. C2000T P667L N.D. N.D. A2230G M744V ↔ Normal G2269A E757K N.D. Intracellular G2459T R820I N.D. N.D. G2560T V854F N.D. N.D. G2698T V900L N.D. N.D. G2867C C956S 1↔ Normal G3211A V1071I ↔ Normal C3425T T1142M N.D. N.D. G3659A R1220Q N.D. N.D. A3941G Q1314R N.D. N.D. 2, reduced function; 1, increased function; ↔, no change in function; N.D. not determined.
X
ABCC5 p.Gly1249Ala 20103563:7118:550
status: NEW
Login to comment

7115 Nucleotide Change Amino Acid Change In Vitro Function Protein Expression/Localization ABCC1 MRP1 G128C C43S 1࢒ Intracellular C218T T73I 1࢒ Normal C257T S92F 2࢒ Normal C350T T117M 2࢒ Normal G689A R230Q ࢒ Normal G1057A V353M N.D. N.D. G1299T R433S 2࢒ Normal G1898A R633Q 2࢒ Normal G2012T G671V ࢒ Normal G2168A R723Q 2 Normal G2965A A989T 2࢒ Normal G3140C C1047S 1࢒ Normal G3173A R1058Q ࢒ Normal C4535T S1512L ࢒ Normal ABCC2 MRP2 C-24T N.D. N.D. G1058A R353H N.D. N.D. G1249A V417I ࢒ Normal C2366T S789F 12 Intracellular T2780G L927R N.D. N.D. C3298T R1100C N.D. N.D. G3299A R1100H N.D. N.D. T3563A V1188E N.D. N.D. G4348A A1450T ࢒ Normal/Intracellular G4544A C1515Y N.D. N.D. ABCC3 MRP3 G32A G11D ࢒ Normal C202T H68Y N.D. N.D. G296A R99Q N.D. Normal C1037T S346F 2 Normal C1537A Q513K N.D. N.D. T1643A L548Q N.D. N.D. G1820A S607N 2 Normal C2221T Gln741STOP N.D. N.D. G2293C V765L ࢒ Normal G2395A V799M N.D. N.D. C2758T P920S 1 Normal G2768A R923Q 1 Normal C3657A S1219R N.D. N.D. C3856G R1286G ࢒ Normal G3890A R1297H N.D. N.D. C4042T R1348C 1 Normal A4094G Q1365R ࢒ Normal C4141A R1381S ࢒ Intracellular C4217T T1406M N.D. N.D. G4267A G1423R N.D. N.D. ABCC4 MRP4 C52A L18I N.D. N.D. C232G P78A 2࢒ Normal T551C M184T N.D. N.D. G559T G187W 2 Reduced A877G K293E ࢒ Normal G912T K304N ࢒ Normal C1067T T356M N.D. N.D. C1208T P403L 2࢒ Normal G1460A G487E 2 Normal A1492G K498E ࢒ Normal A1875G I625M N.D. N.D. C2000T P667L N.D. N.D. A2230G M744V ࢒ Normal G2269A E757K N.D. Intracellular G2459T R820I N.D. N.D. G2560T V854F N.D. N.D. G2698T V900L N.D. N.D. G2867C C956S 1࢒ Normal G3211A V1071I ࢒ Normal C3425T T1142M N.D. N.D. G3659A R1220Q N.D. N.D. A3941G Q1314R N.D. N.D. 2, reduced function; 1, increased function; ࢒, no change in function; N.D. not determined.
X
ABCC5 p.Gly1249Ala 20103563:7115:538
status: NEW
Login to comment

PMID: 15821043 [PubMed] Meyer zu Schwabedissen HE et al: "Variable expression of MRP2 (ABCC2) in human placenta: influence of gestational age and cellular differentiation."
No. Sentence Comment
35 In this paper we demonstrate a significant reduced expression in preterm placenta, increased expression during in vitro differentiation, and an influence of the G1249A polymorphism.
X
ABCC5 p.Gly1249Ala 15821043:35:161
status: NEW
Login to comment

120 These primers were used for amplification of a 301-bp fragment in the 5Ј-flanking region containing the C-24T variant of a 260-bp fragment in exon 10 containing the G1249A variant, and of a 184-bp fragment in exon 28 containing the 3972 polymorphism.
X
ABCC5 p.Gly1249Ala 15821043:120:171
status: NEW
Login to comment

186 Moreover, 5 homozygotes and 16 heterozygotes of the missense mutation G1249A (exon 10) were identified.
X
ABCC5 p.Gly1249Ala 15821043:186:70
status: NEW
Login to comment

215 Protein expression of MRP2, which has been established in a subset of the placental samples, did not differ in relation to the G1249A genotype [mean relative band intensity Ϯ S.D.; terms: 1249 GG, 0.77 Ϯ 0.28 (n ϭ 6), and terms: 1249 GA, 1.00 Ϯ 0.30 (n ϭ 7); Kruskal-Wallis test: ␹2 ϭ 1.479; df ϭ 1; p ϭ 0.224].
X
ABCC5 p.Gly1249Ala 15821043:215:127
status: NEW
Login to comment

PMID: 21606946 [PubMed] Ansari M et al: "Polymorphism in multidrug resistance-associated protein gene 3 is associated with outcomes in childhood acute lymphoblastic leukemia."
No. Sentence Comment
131 Several polymorphisms have been widely studied in MRP2 gene including 50 UTR C-24 T substitution and non-synonymous G1249A, T3563A and G4544A variations leading to Val417Ile, Val1188Glu and Cys1515Tyr amino-acid replacements, respectively.
X
ABCC5 p.Gly1249Ala 21606946:131:116
status: NEW
Login to comment